This protocol is judged by an institutional overview board, an unbiased team that critiques any medical trials involving individuals. If a review includes a Program I drug, as soon as the board approves the protocol as moral, the scientists should submit an application for an investigational new drug (IND) number through the FDA.When beneath the i